FDA advisors recommend GSK’s RSV vaccine for older adults, but flag potential safety risks

Submitted by admin on March 1, 2023 - 6:56pm

Source:

CNBC

News Tags:

Headline:

snippet:

A majority of the FDA panel said GSK’s vaccine safety data was adequate, and the advisors were unanimous that the shot’s efficacy was good.
But the advisors expressed concern that the shots could be associated with risks of rare nervous system disorders such as Guillain-Barre syndrome.
The FDA is expected to make a decision on GSK’s vaccine May 3.

Search form